PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Marius Ivănuță

Grigore T. Popa University of Medicine and Pharmacy

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know

Medical Sciences

A rigorous narrative review of mechanistic and clinical evidence suggesting SGLT2 inhibitors may reduce nephrolithiasis risk, but based on short-term surrogate endpoints and observational data lacking standardized stone outcomes, requiring confirmation in dedicated randomized trials.

PromisingIonuț Nistor Marius Ivănuță Alexandra Haută

Reported

Number of studies included15

Search date1 July 2026

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support